Literature DB >> 15361708

Gene expression levels of cytokines in peritoneal washings from patients with gastric cancer.

Masahide Ikeguchi1, Sachiko Matsumoto, Daiki Murakami, Shingo Kanaji, Shotaro Ohro, Yoshihiko Maeta, Shigeru Tatebe, Akira Kondo, Shun-ichi Tsujitani, Nobuaki Kaibara.   

Abstract

Peritoneal seeding is frequently detected in patients with gastric cancer. The peritoneal cavity is a compartment in which the immunologic host-tumor interaction can occur. Here, we investigated the gene expression levels of cytokines, and compared these gene expressions with the progression of gastric cancer. Total RNA was extracted from 50 ml of peritoneal washings from 78 patients with gastric cancer and 11 noncancerous patients. The gene expression levels of transforming growth factor-beta (TGF-beta), interleukin (IL)-2, IL-6 and IL-12 were analyzed by real-time reverse transcription-polymerase chain reaction. The gene expression levels of TGF-beta and IL-12 in 16 patients with peritoneal seeding (peritoneal metastasis or free cancer cells) did not differ from those in controls (n = 11) and stage I and II (n = 43) patients. However, the relative gene expression level of IL-2 in patients with peritoneal seeding (0.9) was lower than that in controls (1.4, p = 0.066) and stage I and II patients (1.4, p = 0.036). In contrast, the relative gene expression level of IL-6 in patients with peritoneal seeding (3.3) was higher than that in control (2.4, p = 0.064) and stage I and II patients (2.6, p = 0.065). Low IL-2 gene and high IL-6 gene expressions in the peritoneal cavity may correlate with cancer development in the peritoneal cavity in patients with gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361708     DOI: 10.1159/000079143

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  1 in total

1.  Detection of cancer cells and gene expression of cytokines in the peritoneal cavity in patients with gastric cancer.

Authors:  Youji Fukumoto; Masahide Ikeguchi; Sachiko Matsumoto; Masashi Inoue; Tomohiro Osaki; Kenji Fukuda; Hiroaki Saito; Shigeru Tatebe; Shun-Ichi Tsujitani
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.